Nippard puts the two approved drugs on top for supervised weight loss and holds retatrutide at B-tier until it is approved.
Recap by typeshit. Post by @boxlifemagazine on Instagram.
A physio fielding years of peptide questions says strong studies are lacking, while noting that a lack of evidence doesn't prove they fail.
Up to half of participants in the two trials of the experimental drug ended up with only mild sleep apnea, per the post.
Bloomberg traces how Amgen used genetic data from Iceland to guide its obesity drug research.
Researchers in Denmark report pancreatic cells that naturally produce GLP-1, the hormone drugs like semaglutide are built to mimic.
Health minister Dzulkefly says the government did not set aside dedicated 2026 budget funds for the two GLP-1 treatments.
The unapproved Lilly drug was confiscated in a dozen enforcement raids, part of a growing crackdown on gray-market retatrutide sellers.
Loading…